Affymax, Inc. (AFFY.W)

AFFY.W on CBOE When Trading NASDAQ Global Select Market

20.46USD
3 Feb 2010
Price Change (% chg)

$0.18 (+0.90%)
Prev Close
$20.46
Open
--
Day's High
$20.67
Day's Low
$19.86
Volume
54,904
Avg. Vol
174,054
52-wk High
$25.64
52-wk Low
$11.79

AFFY.W

Chart for AFFY.W

About

Affymax, Inc. is a biopharmaceutical company developing peptide-based drugs to improve the treatment of serious and often life-threatening conditions. The Company's product candidate, Hematide, is designed to treat anemia associated with chronic renal failure. Hematide is a relatively small synthetic peptide-based erythropoiesis... (more)

Overall

Beta: 0.82
Market Cap (Mil.): $469.88
Shares Outstanding (Mil.): 23.19
Annual Dividend: 0.00
Yield (%): NA

Financials

  AFFY.W Industry Sector
P/E (TTM): -- 1.96 3.76
EPS (TTM): -4.62 -- --
ROI: -135.62 0.92 2.30
ROE: -598.61 1.27 2.82
view overview for:

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $62.76 +0.39
Amgen, Inc. (AMGN.OQ) $57.21 -0.25
Roche Holding Ltd. (ROG.VX) CHF176.20 +0.10
Merck & Co., Inc. (MRK.N) $36.47 -0.12

  Earnings  vs    Estimates

view overview for: